Technical Analysis for VCNX - Vaccinex, Inc.

Grade Last Price % Change Price Change
grade B 7.31 11.60% 0.76
VCNX closed up 11.6 percent on Friday, September 20, 2019, on 1.56 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical VCNX trend table...

Date Alert Name Type % Chg
Stochastic Reached Overbought Strength 0.00%
BB Squeeze Ended Range Expansion 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Expansion Breakout Bullish Swing Setup 11.60%
Bollinger Band Squeeze Range Contraction 11.60%
Wide Range Bar Range Expansion 11.60%
20 DMA Support Bullish 20.43%

Older signals for VCNX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Vaccinex Inc. is a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics. The Company is focused on providing treatments for serious diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. It provides SEMA4D antibody platform, which is focused on developing its lead product candidate VX15/2503 (VX15) for the treatment of non-small cell lung cancer, NSCLC, osteosarcoma, melanoma and Huntington’s disease. It also provides ActiveMAb antibody discovery platform, a human antibody discovery platform used for expressing large and diverse libraries of high affinity, full-length human monoclonal antibodies on the surface of vaccinia, a mammalian virus. Its product candidate VX5 is in preclinical development for the treatment of multiple sclerosis and potentially for other autoimmune disorders.
Biotechnology Health Cancer Biology Immunology Antibodies Immune System Monoclonal Antibodies Non Small Cell Lung Cancer Multiple Sclerosis Antibody Melanoma Serious Diseases Autoimmune Disorders Neurodegenerative Diseases Treatment Of Non Small Cell Lung Cancer Osteosarcoma Treatment Of Multiple Sclerosis Nsclc Seth Lederman Tolerx
Is VCNX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 10.05
52 Week Low 3.32
Average Volume 5,332
200-Day Moving Average 5.311
50-Day Moving Average 5.1406
20-Day Moving Average 5.9012
10-Day Moving Average 6.1215
Average True Range 0.4341
ADX 12.02
+DI 33.1622
-DI 18.5375
Chandelier Exit (Long, 3 ATRs ) 6.0607
Chandelier Exit (Short, 3 ATRs ) 6.2067
Upper Bollinger Band 6.7384
Lower Bollinger Band 5.064
Percent B (%b) 1.34
BandWidth 28.37389
MACD Line 0.3689
MACD Signal Line 0.2738
MACD Histogram 0.0951
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.53
Resistance 3 (R3) 8.41 7.89 8.33
Resistance 2 (R2) 7.89 7.58 7.95 8.26
Resistance 1 (R1) 7.60 7.38 7.74 7.72 8.19
Pivot Point 7.07 7.07 7.15 7.13 7.07
Support 1 (S1) 6.79 6.76 6.93 6.90 6.43
Support 2 (S2) 6.26 6.57 6.32 6.36
Support 3 (S3) 5.97 6.26 6.29
Support 4 (S4) 6.09